Patent · US Expired

Hypoallergenic mutant polypeptides based on fish parvalbumin

US7696314B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2004
Grant dateApr 13, 2010
Priority date
Expiry dateNov 21, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to non-naturally occurring polypeptides derived from fish allergens such as parvalbumin Cyp c 1.01 from carp. The polypeptides display reduced allergenic activity and are useful as allergy vaccines for treatment of sensitized allergic patients and for prophylactic vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.